The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), VASOSTRICT Injection 40 Units per 100 mL and 20 Units per 100 mL of PH Health Limited
Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role
Collaboration reinforces Boehringer Ingelheim’s expertise in microbial contract development and manufacturing
The company is bringing precision therapies for gynaecological cancers
The company has improved access to quality healthcare for seniors across both urban and rural areas
Astaxanthin is a powerful antioxidant and red-orange carotenoid pigment found in various aquatic organisms
The facility will be positioned as a Centre of Excellence for tertiary care services
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
This acquisition expands HGM's healthcare platform capabilities in revenue cycle management
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
Subscribe To Our Newsletter & Stay Updated
